Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19

We presented the clinical course and immune responses of a well-controlled HIV-positive patient with COVID-19. The clinical presentation and antibody production to SARS-CoV-2 were similar to other COVID-19 patients without HIV infection. Neutralizing antibody reached a plateau from 26th to 47th day...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wang-Da Liu, Chien-Ching Hung, Jann-Tay Wang, Ming-Jui Tsai, Po-Hsien Kuo, Tai-Ling Chao, Szu-Min Hsieh, Wang-Huei Sheng, Yee-Chun Chen, Sui-Yuan Chang, Shan-Chwen Chang
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Antiretroviral therapy Coronavirus Enzyme-linked immunosorbent assay (ELISA) Plaque reduction assay Severe acute respiratory syndrome Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/6c68ae0190b84843af686b82c3f5a65f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6c68ae0190b84843af686b82c3f5a65f
record_format	dspace
spelling	oai:doaj.org-article:6c68ae0190b84843af686b82c3f5a65f2021-12-02T04:59:10ZEvolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-190929-664610.1016/j.jfma.2021.04.010https://doaj.org/article/6c68ae0190b84843af686b82c3f5a65f2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0929664621001674https://doaj.org/toc/0929-6646We presented the clinical course and immune responses of a well-controlled HIV-positive patient with COVID-19. The clinical presentation and antibody production to SARS-CoV-2 were similar to other COVID-19 patients without HIV infection. Neutralizing antibody reached a plateau from 26th to 47th day onset but decreased on 157th day after symptoms.Wang-Da LiuChien-Ching HungJann-Tay WangMing-Jui TsaiPo-Hsien KuoTai-Ling ChaoSzu-Min HsiehWang-Huei ShengYee-Chun ChenSui-Yuan ChangShan-Chwen ChangElsevierarticleAntiretroviral therapyCoronavirusEnzyme-linked immunosorbent assay (ELISA)Plaque reduction assaySevere acute respiratory syndromeMedicine (General)R5-920ENJournal of the Formosan Medical Association, Vol 120, Iss 12, Pp 2186-2190 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Antiretroviral therapy Coronavirus Enzyme-linked immunosorbent assay (ELISA) Plaque reduction assay Severe acute respiratory syndrome Medicine (General) R5-920
spellingShingle	Antiretroviral therapy Coronavirus Enzyme-linked immunosorbent assay (ELISA) Plaque reduction assay Severe acute respiratory syndrome Medicine (General) R5-920 Wang-Da Liu Chien-Ching Hung Jann-Tay Wang Ming-Jui Tsai Po-Hsien Kuo Tai-Ling Chao Szu-Min Hsieh Wang-Huei Sheng Yee-Chun Chen Sui-Yuan Chang Shan-Chwen Chang Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
description	We presented the clinical course and immune responses of a well-controlled HIV-positive patient with COVID-19. The clinical presentation and antibody production to SARS-CoV-2 were similar to other COVID-19 patients without HIV infection. Neutralizing antibody reached a plateau from 26th to 47th day onset but decreased on 157th day after symptoms.
format	article
author	Wang-Da Liu Chien-Ching Hung Jann-Tay Wang Ming-Jui Tsai Po-Hsien Kuo Tai-Ling Chao Szu-Min Hsieh Wang-Huei Sheng Yee-Chun Chen Sui-Yuan Chang Shan-Chwen Chang
author_facet	Wang-Da Liu Chien-Ching Hung Jann-Tay Wang Ming-Jui Tsai Po-Hsien Kuo Tai-Ling Chao Szu-Min Hsieh Wang-Huei Sheng Yee-Chun Chen Sui-Yuan Chang Shan-Chwen Chang
author_sort	Wang-Da Liu
title	Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
title_short	Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
title_full	Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
title_fullStr	Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
title_full_unstemmed	Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
title_sort	evolution of sars-cov-2 neutralizing antibody in an hiv-positive patient with covid-19
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/6c68ae0190b84843af686b82c3f5a65f
work_keys_str_mv	AT wangdaliu evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19 AT chienchinghung evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19 AT janntaywang evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19 AT mingjuitsai evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19 AT pohsienkuo evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19 AT tailingchao evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19 AT szuminhsieh evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19 AT wanghueisheng evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19 AT yeechunchen evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19 AT suiyuanchang evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19 AT shanchwenchang evolutionofsarscov2neutralizingantibodyinanhivpositivepatientwithcovid19
_version_	1718400894047879168

Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19

Ejemplares similares